Anti-CCR8 agents

JP2026095523APending Publication Date: 2026-06-11MEMORIAL SLOAN KETTERING CANCER CENT
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
MEMORIAL SLOAN KETTERING CANCER CENT
Filing Date
2026-03-27
Publication Date
2026-06-11

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

Provision of anti-CCR8 agents. [Solution] The present invention provides methods and compositions for diagnosing and / or treating cancer, in particular by targeting CCR8. In particular, the present invention provides techniques for depleting Treg cells, and specifically tumor-infiltrating Treg cells. The present invention recognizes the need for improved cancer treatment. This disclosure recognizes that depletion of tumor-infiltrating regulatory T cells (Tregs) improves the immune response against tumors.
Need to check novelty before this filing date? Find Prior Art